Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Perry, PJ; Lund, BC; Sanger, T; Besley, C
   Olanzapine plasma concentrations and clinical response: Acute phase results of the North American Olanzapine Trial
   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
   
   P.J. Perry et al., "Olanzapine plasma concentrations and clinical response: Acute phase results of the North American Olanzapine Trial", J CL PSYCH, 21(1), 2001, pp. 14-20
2. Tohen, M; Zhang, F; Taylor, CC; Burns, P; Zarate, C; Sanger, T; Tollefson, G
   A meta-analysis of the use of typical antipsychotic agents in bipolar disorder
   JOURNAL OF AFFECTIVE DISORDERS
   
   M. Tohen et al., "A meta-analysis of the use of typical antipsychotic agents in bipolar disorder", J AFFECT D, 65(1), 2001, pp. 85-93
3. Voss, SN; Sanger, T; Beasley, C
   Hematologic reference ranges in a population of patients with schizophrenia
   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
   
   S.N. Voss et al., "Hematologic reference ranges in a population of patients with schizophrenia", J CL PSYCH, 20(6), 2000, pp. 653-657
4. Tohen, M; Jacobs, TG; Grundy, SL; McElroy, SL; Banov, MC; Janicak, PG; Sanger, T; Risser, R; Zhang, F; Toma, V; Francis, J; Tollefson, GD; Breier, A
   Efficacy of olanzapine in acute bipolar mania - A double-blind, placebo-controlled study
   ARCHIVES OF GENERAL PSYCHIATRY
   
   M. Tohen et al., "Efficacy of olanzapine in acute bipolar mania - A double-blind, placebo-controlled study", ARCH G PSYC, 57(9), 2000, pp. 841-849
5. Perry, PJ; Sanger, T; Beasley, CM
   Plasma olanzapine and clinical response: Reply
   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
   
   P.J. Perry et al., "Plasma olanzapine and clinical response: Reply", J CL PSYCH, 19(2), 1999, pp. 193-194
6. TRAN P; LU Y; SANGER T; BEASLEY C; TOLLEFSON G
   OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER
   Schizophrenia research
   
   P. Tran et al., "OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER", Schizophrenia research, 29(1-2), 1998, pp. 151-151
7. SO GM; THIELE EA; SANGER T; SCHMID R; RIVIELLO JJ
   ELECTROENCEPHALOGRAM AND CLINICAL FOCALITIES IN JUVENILE MYOCLONIC EPILEPSY
   Journal of child neurology
   
   G.M. So et al., "ELECTROENCEPHALOGRAM AND CLINICAL FOCALITIES IN JUVENILE MYOCLONIC EPILEPSY", Journal of child neurology, 13(11), 1998, pp. 541-545
8. ZERA AJ; SANGER T; CISPER GL
   DIRECT AND CORRELATED RESPONSES TO SELECTION ON JHE ACTIVITY IN ADULTAND JUVENILE GRYLLUS-ASSIMILIS - IMPLICATIONS FOR STAGE-SPECIFIC EVOLUTION OF INSECT ENDOCRINE TRAITS
   Heredity
   
   A.J. Zera et al., "DIRECT AND CORRELATED RESPONSES TO SELECTION ON JHE ACTIVITY IN ADULTAND JUVENILE GRYLLUS-ASSIMILIS - IMPLICATIONS FOR STAGE-SPECIFIC EVOLUTION OF INSECT ENDOCRINE TRAITS", Heredity, 80, 1998, pp. 300-309
9. PERRY PJ; SANGER T; BEASLEY C
   OLANZAPINE PLASMA-CONCENTRATIONS AND CLINICAL-RESPONSE IN ACUTELY ILLSCHIZOPHRENIC-PATIENTS
   Journal of clinical psychopharmacology
   
   P.J. Perry et al., "OLANZAPINE PLASMA-CONCENTRATIONS AND CLINICAL-RESPONSE IN ACUTELY ILLSCHIZOPHRENIC-PATIENTS", Journal of clinical psychopharmacology, 17(6), 1997, pp. 472-477
10. BEASLEY CM; TOLLEFSON G; TRAN P; SATTERLEE W; SANGER T; HAMILTON S; FABRE L; SMALL J; ERESHEFSKY L; TRUE J; NEMEROFF C; RISCH SC; PERRY PJ; POTKIN SG; BORISON RL; JAMES S; MELTZER HY; IQBAL N; FANN WE; GEWIRTZ GR; LANDBLOOM R; ROYBYRNE PP; TUASON VB; CARMAN JS; STOKES PE; WILLIAMS R; ANCILL RJ; MACEWAN GW; GUJAVARTY KS; JONES B; LOHR JB
    OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - ACUTE-PHASE RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND OLANZAPINE TRIAL
    Neuropsychopharmacology
    
    C.M. Beasley et al., "OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - ACUTE-PHASE RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND OLANZAPINE TRIAL", Neuropsychopharmacology, 14(2), 1996, pp. 111-123
11. STREET JS; TAMURA R; SANGER T; TOLLEFSON O
    LONG-TERM TREATMENT-EMERGENT DYSKINETIC SYMPTOMS IN PATIENTS TREATED WITH OLANZAPINE AND HALOPERIDOL
    Psychopharmacology bulletin
    
    J.S. Street et al., "LONG-TERM TREATMENT-EMERGENT DYSKINETIC SYMPTOMS IN PATIENTS TREATED WITH OLANZAPINE AND HALOPERIDOL", Psychopharmacology bulletin, 32(3), 1996, pp. 522-522
12. TRAN P; LU YL; SANGER T; BEASLEY C; TOLLEFSON G
    OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER
    Psychopharmacology bulletin
    
    P. Tran et al., "OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER", Psychopharmacology bulletin, 32(3), 1996, pp. 527-527
13. BEASLEY CM; SANGER T; SATTERLEE W; TOLLEFSON G; TRAN P; HAMILTON S; GREEN A; DOTT S; PFISTER G; ROXAS L; SMALL J; THOMAS M; AMES D; SCHOOLER N; BAKER R; LEVINE R; FABRE L; FRIEDEL R; SAFFERMAN A; LIEBERMAN J; STAHL S
    OLANZAPINE VERSUS PLACEBO - RESULTS OF A DOUBLE-BLIND, FIXED-DOSE OLANZAPINE TRIAL
    Psychopharmacology
    
    C.M. Beasley et al., "OLANZAPINE VERSUS PLACEBO - RESULTS OF A DOUBLE-BLIND, FIXED-DOSE OLANZAPINE TRIAL", Psychopharmacology, 124(1-2), 1996, pp. 159-167
14. SATTERLEE W; BEASLEY C; SANGER T; TOLLEFSON G
    ADDITIONAL CLINICAL-EXPERIENCE WITH OLANZAPINE, AN ATYPICAL ANTIPSYCHOTIC
    Schizophrenia research
    
    W. Satterlee et al., "ADDITIONAL CLINICAL-EXPERIENCE WITH OLANZAPINE, AN ATYPICAL ANTIPSYCHOTIC", Schizophrenia research, 15(1-2), 1995, pp. 163-163
15. SATTERLEE W; BEASLEY C; SANGER T; TRAN P; TOLLEFSON G
    OLANZAPINE, A NEW ATYPICAL ANTIPSYCHOTIC
    Schizophrenia research
    
    W. Satterlee et al., "OLANZAPINE, A NEW ATYPICAL ANTIPSYCHOTIC", Schizophrenia research, 15(1-2), 1995, pp. 163-164
16. TOLLEFSON GD; BEASLEY CM; TRAN PV; SANGER T
    OLANZAPINE - A NOVEL ANTIPSYCHOTIC WITH A BROAD-SPECTRUM PROFILE
    Biological psychiatry
    
    G.D. Tollefson et al., "OLANZAPINE - A NOVEL ANTIPSYCHOTIC WITH A BROAD-SPECTRUM PROFILE", Biological psychiatry, 35(9), 1994, pp. 746-747